The Initial Risk Stratification System for Differentiated Thyroid Cancer: Key Updates in the 2024 Korean Thyroid Association Guideline
Endocrinology and Metabolism · 2025
DOI: 10.3803/enm.2025.2465 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrinology and Metabolism, 2025. Verfasst von Shinje Moon und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Hanyang University Seoul Hospital, Seoul, Korea. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Practice Guidelines as Topic. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Cancer Center, Patient-Centered Clinical Research Coordinating Center, Ministry of Health and Welfare.
Abstract (Originalsprache)
In 2024, the Korean Thyroid Association (KTA) introduced a revised Risk Stratification System (K-RSS) for differentiated thyroid cancer, building upon the modified RSS (M-RSS) proposed by the American Thyroid Association in 2015. The K-RSS emphasizes the cumulative impact of coexisting clinical and pathological features, acknowledging that multiple intermediate-risk factors collectively indicate a higher recurrence risk. Histologic classification follows the 2022 World Health Organization classification, consolidating encapsulated follicular-patterned thyroid carcinomas, including invasive encapsulated follicular variant papillary thyroid carcinoma, follicular thyroid carcinoma, and oncocytic carcinoma of the thyroid gland, and stratifying them by the extent of capsular and vascular invasion. High-grade thyroid carcinoma is newly included. Updated criteria for tumor size and extrathyroidal extension (ETE) represent another significant change. BRAFV600E-mutated papillary thyroid carcinomas measuring 1 to 2 cm are now considered lower risk than previously classified in the M-RSS, while encapsulated follicular-patterned tumors larger than 4 cm are considered higher risk. Both minimal ETE and gross ETE confined to the strap muscles have been downgraded to low and intermediate risk, respectively. These changes are accompanied by updates regarding molecular profiling and surgical margin status. Collectively, these updates aim to minimize overtreatment in low-risk patients, while ensuring intensified management for those at higher risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Hanyang University Seoul Hospital, Seoul, Korea.
- Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea.
- Department of Internal Medicine, Nowon Eulji Medical Center, Eulji University, Seoul, Korea.
- Department of Internal Medicine, National Cancer Center, Goyang, Korea.
- Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Förderung
- National Cancer Center
- Patient-Centered Clinical Research Coordinating Center
- Ministry of Health and Welfare
Zitieren
APA
Moon, S., Song, Y. S., Jung, K. Y., Lee, E. K., Lee, J., Lim, D. J., Jung, C. K., Park, Y. J., & Korean Thyroid Association Clinical Guideline Committee (2025). The Initial Risk Stratification System for Differentiated Thyroid Cancer: Key Updates in the 2024 Korean Thyroid Association Guideline. Endocrinology and Metabolism. https://doi.org/10.3803/enm.2025.2465
Vancouver
Moon S, Song YS, Jung KY, Lee EK, Lee J, Lim DJ, et al. The Initial Risk Stratification System for Differentiated Thyroid Cancer: Key Updates in the 2024 Korean Thyroid Association Guideline. Endocrinology and Metabolism. 2025. doi:10.3803/enm.2025.2465
BibTeX
@article{Moon2025,
author = {Moon, Shinje and Song, Young Shin and Jung, Kyong Yeun and Lee, Eun Kyung and Lee, Jeongmin and Lim, Dong-Jun and Jung, Chan Kwon and Park, Young Joo and Korean Thyroid Association Clinical Guideline Committee, Korean Thyroid Association Clinical Guideline Committee},
title = {The Initial Risk Stratification System for Differentiated Thyroid Cancer: Key Updates in the 2024 Korean Thyroid Association Guideline},
journal = {Endocrinology and Metabolism},
year = {2025},
doi = {10.3803/enm.2025.2465}
}
EUVIMED